228 related articles for article (PubMed ID: 34633845)
21. Phylogeny, Antifungal Susceptibility, and Point Mutations of
Pashootan N; Shams-Ghahfarokhi M; Chaichi Nusrati A; Salehi Z; Asmar M; Razzaghi-Abyaneh M
Front Cell Infect Microbiol; 2022; 12():851769. PubMed ID: 35372131
[TBL] [Abstract][Full Text] [Related]
22. MIC and Upper Limit of Wild-Type Distribution for 13 Antifungal Agents against a Trichophyton mentagrophytes-Trichophyton interdigitale Complex of Indian Origin.
Shaw D; Singh S; Dogra S; Jayaraman J; Bhat R; Panda S; Chakrabarti A; Anjum N; Chowdappa A; Nagamoti M; Varshney U; Vanam HP; Savio J; Antony M; Rudramurthy SM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015042
[TBL] [Abstract][Full Text] [Related]
23. The Domestic Isolation of Terbinafine- and Itraconazole-Resistant Trichophyton indotineae in Chinese Mainland.
Kong X; Song G; Mei H; Zheng H; Tang C; de Hoog S; Li X; She X; Liu W; Liang G
Mycopathologia; 2023 Aug; 188(4):383-393. PubMed ID: 37335400
[TBL] [Abstract][Full Text] [Related]
24. Report of terbinafine resistant Trichophyton spp. in Italy: Clinical presentations, molecular identification, antifungal susceptibility testing and mutations in the squalene epoxidase gene.
Bortoluzzi P; Prigitano A; Sechi A; Boneschi V; Germiniasi F; Esposto MC; Romanò L; Pavan G; Matinato C; Veraldi S; Marzano AV; Grancini A
Mycoses; 2023 Aug; 66(8):680-687. PubMed ID: 37139949
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
[TBL] [Abstract][Full Text] [Related]
26. High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene.
Singh A; Masih A; Khurana A; Singh PK; Gupta M; Hagen F; Meis JF; Chowdhary A
Mycoses; 2018 Jul; 61(7):477-484. PubMed ID: 29577447
[TBL] [Abstract][Full Text] [Related]
27. Terbinafine resistance in Trichophyton mentagrophytes and Trichophyton rubrum in the Czech Republic: A prospective multicentric study.
Kolarczyková D; Lysková P; Švarcová M; Kuklová I; Dobiáš R; Mallátová N; Kolařík M; Hubka V
Mycoses; 2024 Feb; 67(2):e13708. PubMed ID: 38404204
[TBL] [Abstract][Full Text] [Related]
28. Case of tinea corporis due to terbinafine-resistant Trichophyton interdigitale.
Kakurai M; Harada K; Maeda T; Hiruma J; Kano R; Demitsu T
J Dermatol; 2020 Apr; 47(4):e104-e105. PubMed ID: 31994232
[No Abstract] [Full Text] [Related]
29. Emerging Terbinafine Resistance in
Saunte DML; Hare RK; Jørgensen KM; Jørgensen R; Deleuran M; Zachariae CO; Thomsen SF; Bjørnskov-Halkier L; Kofoed K; Arendrup MC
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383665
[TBL] [Abstract][Full Text] [Related]
30. Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study.
Badiee P; Shokohi T; Hashemi J; Mohammadi R; Najafzadeh MJ; Amin Shahidi M; Ghasemi F; Jafarian H
Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):15. PubMed ID: 36805670
[TBL] [Abstract][Full Text] [Related]
31. Trichophyton indotineae, from epidemiology to therapeutic.
Jabet A; Normand AC; Brun S; Dannaoui E; Bachmeyer C; Piarroux R; Hennequin C; Moreno-Sabater A
J Mycol Med; 2023 Aug; 33(3):101383. PubMed ID: 37031652
[TBL] [Abstract][Full Text] [Related]
32. Epidemiological study of antifungal-resistant dermatophytes isolated from Japanese patients.
Hiruma J; Noguchi H; Shimizu T; Hiruma M; Harada K; Kano R
J Dermatol; 2023 Aug; 50(8):1068-1071. PubMed ID: 36938668
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A).
Barros MEDS; Santos DA; Hamdan JS
J Med Microbiol; 2007 Apr; 56(Pt 4):514-518. PubMed ID: 17374893
[TBL] [Abstract][Full Text] [Related]
34. Synergistic effects of terbinafine and itraconazole on clinical isolates of Fonsecaea monophora.
ZHANG JM; XI LY; ZHANG H; XIE Z; SUN JF; LI XQ; LU S
Eur J Dermatol; 2009; 19(5):451-5. PubMed ID: 19502155
[TBL] [Abstract][Full Text] [Related]
35. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum.
Fernández-Torres B; Vázquez-Veiga H; Llovo X; Pereiro M; Guarro J
Chemotherapy; 2000; 46(6):390-4. PubMed ID: 11053904
[TBL] [Abstract][Full Text] [Related]
36. Antifungal resistance in superficial mycoses.
Gupta AK; Venkataraman M
J Dermatolog Treat; 2022 Jun; 33(4):1888-1895. PubMed ID: 34132155
[TBL] [Abstract][Full Text] [Related]
37. Molecular Verification of Trichophyton in the Brazilian URM Culture Collection.
Oliveira TF; Valeriano CAT; Buonafina-Paz MDS; Souza-Motta CM; Machado AR; Neves RP; Bezerra JDP; Arantes TD; de Hoog S; Magalhães OMC
Mycopathologia; 2024 Jan; 189(1):2. PubMed ID: 38217794
[TBL] [Abstract][Full Text] [Related]
38. Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Salehi Z; Fatahi N; Taran M; Izadi A; Badali H; Hashemi SJ; Rezaie S; Daie Ghazvini R; Ghaffari M; Aala F; Barac A; Khodavaisy S
J Mycol Med; 2020 Jun; 30(2):100935. PubMed ID: 32139093
[TBL] [Abstract][Full Text] [Related]
39. Disinfection trials with terbinafine-susceptible and terbinafine-resistant dermatophytes.
Skaastrup KN; Astvad KMT; Arendrup MC; Jemec GBE; Saunte DML
Mycoses; 2022 Jul; 65(7):741-746. PubMed ID: 35535729
[TBL] [Abstract][Full Text] [Related]
40. Molecular identification and antifungal susceptibility of 75 clinical isolates of Trichophyton spp. from southern Brazil.
Koehler A; Ribeiro AC; Pagani DM; Vettorato R; Magagnin CM; Stopiglia CDO; Heidrich D; Scroferneker ML
J Mycol Med; 2021 Dec; 31(4):101201. PubMed ID: 34474264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
